2020 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 220 % |
Worst rating | -490 % |
New companies | 7 |
Negative Economic Capital Ratio | 17 of 52 |
Financial Strength Rankings using Artificial Intelligence
Top rated | 13 of 52 |
Best rating | 220 % |
Worst rating | -490 % |
New companies | 7 |
Negative Economic Capital Ratio | 17 of 52 |
Phoenix Life Sciences International Limited. climbed 29 positions from 43 to 14 due to its excellent Goodwill.MARIMED INC. lost 36 positions from 9 to 45 due to its bad Assets, Current.Cronos Group Inc. entered the 2020 ranking at rank 1, making it the best newcomer.
Revenues | 37.3 B |
Assets | 60.1 B |
Expenses | 36.0 B |
Stockholders Equity | 24.7 B |
Unprofitable Companies | 33 of 52 |
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the U.S. Brokerage [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the German Disability [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the German Life [...]
Source: https://openai.com/dall-e-3/ The results for RealRate’s 2024 ranking for the German Health [...]
Source: https://openai.com/dall-e-3/ RealRate is extremely excited to announce that the new 2024 German [...]
Some incredible news from RealRate HQ We have successfully graduated from the [...]
Source: https://openai.com/dall-e-3/ Last Sunday RealRate had a birthday of sorts. It was [...]
We have some exciting news from the actuarial world! Dr. Holger Bartel, [...]
This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai